Skinvive 3cc & LDM 1 Session
Skinvive is an HA-injection treatment that improves long term moisturaizing and glowing skin. SKINVIVE by JUVEDERM is a hyaluronic-acid injectable placed into the dermis, and its manufacturer positions it for skin smoothness rather than for adding volume. Its approved wording is not the same in every country: the U.S. FDA indication and the Korean product wording describe different things, and because treatment happens in Korea, the Korean wording is the one that applies to you. Material and placement: Hyaluronic acid, injected intradermally U.S. approval record: PMA P110033/S059, approved 11 May 2023, applicant Allergan U.S. indicated wording: Intradermal injection to improve facial skin smoothness of the cheeks, age 21 and older Korean product wording: Tissue-restoration biomaterial; temporary improvement of moderate to severe fine lines on the cheeks of the face in adults What is SKINVIVE by JUVEDERM? It is a hyaluronic-acid (HA) injectable placed into the dermis, sold within the JUVEDERM collection. The U.S. Food and Drug Administration lists it under premarket approval P110033 supplement S059, approved on 11 May 2023, with Allergan as the applicant. The database record files it under product code LMH with the generic name Implant, dermal, for aesthetic use, and the supplement is a Panel Track supplement — meaning it was added to an existing premarket approval after review rather than issued as a brand-new standalone approval.
Skinvive · LDM Ultrasound Care
提供病院 Abijou Clinic Hongdae